Home/Filings/4/0001415889-25-001779
4//SEC Filing

Quan Joanne 4

Accession 0001415889-25-001779

CIK 0001759425other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:21 PM ET

Size

8.8 KB

Accession

0001415889-25-001779

Insider Transaction Report

Form 4
Period: 2025-01-16
Quan Joanne
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-16+12,50012,618 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-1612,50025,000 total
    Common Stock (12,500 underlying)
  • Sale

    Common Stock

    2025-01-17$45.86/sh6,969$319,5985,649 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • [F3]1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1
  • filerCIK 0001670138

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:21 PM ET
Size
8.8 KB